Sales rise 7.64% to Rs 280.46 crore
Net profit of ERIS Lifesciences rose 8.66% to Rs 92.71 crore in the quarter ended September 2019 as against Rs 85.32 crore during the previous quarter ended September 2018. Sales rose 7.64% to Rs 280.46 crore in the quarter ended September 2019 as against Rs 260.56 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales280.46260.56 8 OPM %39.1738.64 -PBDT114.50100.59 14 PBT102.7792.31 11 NP92.7185.32 9Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
